Showing results (1071-1080 of 4,702) with videos related to
Sort By:
Pageof 471
Seminars in Oncology|April 1, 1988
Monoclonal antibodies in gastrointestinal cancersE P Mitchell, J SchlomSeminars in Oncology|April 1, 1988
Megestrol acetate-induced differentiation of 3T3-L1 adipocytes in vitroA W Hamburger, H Parnes, G B Gordon, et al.Seminars in Oncology|February 26, 2014
Invasive and noninvasive advances in the staging of lung cancerFabien Maldonado, James R JettSeminars in Oncology|April 12, 2017
Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approachMichele Boisdron-Celle, Olivier Capitain, Roger Faroux, et al.Seminars in Oncology|April 12, 2017
A multicenter phase II study of personalized FOLFIRI-cetuximab for safe dose intensificationMichèle Boisdron-Celle, Jean Philippe Metges, Olivier Capitain, et al.Seminars in Oncology|April 12, 2017
Characterization of outcomes in patients with metastatic non-small cell lung cancer treated with programmed cell death protein 1 inhibitors past RECIST version 1.1-defined disease progression in clinical trialsDickran Kazandjian, Patricia Keegan, Daniel L Suzman, et al.Seminars in Oncology|April 12, 2017
Screening for lung cancerHeather F Sateia, Youngjee Choi, Rosalyn W Stewart, et al.Seminars in Oncology|June 1, 1988
Cisplatin plus etoposide in small cell lung cancerP J Loehrer, L H Einhorn, F A GrecoSeminars in Oncology|June 1, 1988
Phase II trial of mitomycin C plus 5-FU in the treatment of drug-refractory ovarian cancerD S Alberts, D Garcia-Kendall, E A SurwitSeminars in Oncology|June 1, 1988
Intraperitoneal mitomycin C in the treatment of peritoneal carcinomatosis following second-look surgeryB J Monk, E A Surwit, D S Alberts, et al.Pageof 471